DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Drug Metabolism and Disposition Fast Forward
First published on April 24, 2008; DOI: 10.1124/dmd.107.020164

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.020164v1
36/7/1414    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Lana X. Garmire
C. Anthony Hunt
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garmire, L. X.
Right arrow Articles by Hunt, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garmire, L. X.
Right arrow Articles by Hunt, C. A.


Received for publication December 18, 2007.
Revised April 22, 2008.
Accepted for publication April 23, 2008.

In Silico Methods for Unraveling the Mechanistic Complexities of Intestinal Absorption: Metabolism–Efflux Transport Interactions

Lana X. Garmire 1 C. Anthony Hunt 2*

1 University of California, Berkeley 2 University of California, San Francisco

* Address correspondence to: E-mail: a.hunt{at}ucsf.edu

Abstract

We present a relatively simple, abstract, yet mechanistically realistic, In Silico Intestinal Device (ISID). Its design enabled exploration of the mechanistic details of absorption for passively absorbed compounds that are also dual substrates of drug metabolizing enzymes (CYP) and transporters (PGP), including P-glycoprotein. CYP and PGP, functioning as validated analogues of their referents, are autonomous software objects within the ISID. These and other autonomous objects were plugged together to form a device-an ISID-that represents intestinal features at different scales and levels of detail. Changes in proximal-to-distal levels of CYP and PGP are represented separately from the mechanisms that influence drug absorption and metabolism. Results for six proximal-to-distal CYP-PGP patterns are presented, along with results for different CYP-PGP ratios and amounts. We detected no CYP-PGP synergy. However, CYP-PGP antagonism was measured. Increasing the PGP/CYP ratio to ten increased compound retention in the simulated lumen, but did not increase total metabolism. Different proximal-to-distal CYP-PGP patterns, with and without simulated non-specific, intracellular binding, had substantial effects on measures of absorption, metabolism, and metabolic extraction ratio within the ISID. The changes were due more to CYP than to PGP. The ISID represents a new class of models that is suitable for experimentation. It expands the repertoire of experimental methods for unraveling the mechanistic details of intestinal drug absorption and in anticipating the absorption consequences of drug interactions.


Key words: absorption, cellular transport, CYP3A, drug absorption, drug efflux, intestinal transport, kinetic modeling, membrane transport, Monte Carlo simulations, p-glycoprotein


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. Park, G. E. P. Ropella, S. H. J. Kim, M. S. Roberts, and C. A. Hunt
Computational Strategies Unravel and Trace How Liver Disease Changes Hepatic Drug Disposition
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 294 - 305.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.